Cite
HARVARD Citation
Prisciandaro, M. et al. (2019). Safety and Efficacy of Cabozantinib for Metastatic Nonclear Renal Cell Carcinoma. American journal of clinical oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Prisciandaro, M. et al. (2019). Safety and Efficacy of Cabozantinib for Metastatic Nonclear Renal Cell Carcinoma. American journal of clinical oncology. p. . [Online].